Strategy Partnerships for Budget Value As we enter Q4, many clinical operations teams face the familiar challenge of budget utilization. In research-driven organizations, unspent funds create pressure to allocate resources quickly. Yet, reactive decisions can compromise study timelines, inflate costs, or affect compliance. The question becomes: how can sponsors and CROs transform year-end budget pressures into a strategic advantage? From Short-Term Spending to Strategic Inves

Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer patients, limited historical data and small global treatment populations, every component of the trial must be executed with precision, especially the sourcing of comparator drugs and ancillary supplies. In rare disease studies patient recruitment is already difficult. Delays due to drug unavailability or supply chain inefficiencies can have a

On November 4th-5th, join CSI’s Managing Director, Vanessa Dekou and Head of Operations, North America, Jonathan Miller at the...

Join us on October 15–16 at the Encore Boston Harbor, MA, for one of the leading events in clinical trial operations, Outsourcing in...

From 14 th -16th October, join CSI's representatives at The Corinthia, Budapest for the leading clinical supply chain event, GCSG Europe...

On 17th–18th September, our Director of Project Management, Stephan Muetze, and Project Manager, Aylin Asadian, will be on-site at the Messe, Düsseldorf, to discuss all things relating to clinical trial supply; from global sourcing to product access and logistics. If you’re attending, come and connect with us to explore how CSI can support your next study.

In the pharmaceutical industry, timelines serve as both operational benchmarks and market signals. When sponsors announce trial starts and milestones, the investment community pays close attention. But what happens when behind-the-scenes issues, such as delays in sourcing a comparator drug, throw those timelines off track? At Clinical Services International (CSI), we have seen firsthand how comparator drug sourcing, though often underestimated, can become a critical path depe

Rapid Supply of Abraxane in Europe Client Request: Urgent Need for Abraxane A global pharmaceutical sponsor was in a tight spot. They needed 450 packs of Abraxane (nab-paclitaxel) for sites across Europe. Unfortunately, their original supplier could not meet the demand within the required timeline. This situation threatened to delay patient enrolment and jeopardise key study milestones. The Challenge: Overcoming Obstacles The project faced several challenges: Short lead time

Your Global Partner in Clinical Trial Supply At Clinical Services International (CSI), we do more than source medicines, we ensure your...

CSI is proud to drive progress and celebrate the power of diversity. Our team is as global as the studies we support. Representing a...

In an industry where both timelines and budgets are under constant pressure, clinical trial sponsors and CROs are often forced to balance the two most critical resources: time and money. At Clinical Services International (CSI), we work with clients around the world navigating this challenge. And whilst cost control is understandably top of mind, it is often time, not price, that defines success. Price Matters… But Isn’t Everything Sponsors and CROs are understandably price-s